1INTRODUCTIONAnemia is common in patients with malignancy. Ludwig et al. performed a prospective survey in 15,367 European cancer patients, and found that at enrolment, the overall prevalence of anemia was 39.3% and patients who received chemotherapy had the highest incidence of anemia at 62.7%. Anemia in cancer patients is multifactorial; nutritional deficiencies (iron, vitamin B12 and folate) are important etiologies.Iron deficiency anemia is one of the commonest forms of nutritional anemia, characterized by inadequate iron stores. Iron deficiency can be a true or functional deficiency. The standard therapy for iron deficiency anemia is iron supplementation, most commonly by oral iron supplements. The established indications for parenteral, that is intravenous (IV) iron supplementation include failure of oral iron, intolerance to oral iron, a condition that confers refractoriness to oral iron (e.g., post‐gastrectomy, celiac disease, atrophic gastritis, H. pylori infection, etc.), need for rapid anemia reversal (e.g., late in pregnancy, chronic bleeding), with erythropoietin stimulating agents (ESA) in chronic renal failure patients and as a substitute for blood transfusions in persons who refuse blood products on religious grounds. In patients on cytotoxic chemotherapy, receiving ESA, who have concomitant iron deficiency or inadequate ESA response, iron supplementation is recommended. Several studies have shown
Asia-Pacific Journal of Clinical Oncology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud